12:00 AM
 | 
Jun 02, 2014
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Veracyte sales and marketing update

Veracyte launched Afirma Malignancy Classifiers in the U.S. to provide preoperative information to help guide surgical strategy in patients with thyroid nodules. Afirma Malignancy Classifiers comprises genomic tests to identify medullary thyroid cancer (MTC)...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >